Firebrick Pharma Group caps off $7m IPO

MELBOURNE: Firebrick Pharma, which is developing a nasal spray for common cold, will list on

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In
Smarter Selling - specialised sales training for aged care teams